Acevedo, R., Fernandez, S., Zayas, C., Acosta, A., Sarmiento, M.E., Ferro, V.A., et al., 2014. Bacterial outer membrane vesicles and vaccine applications. Front Immunol 5, 121.

Ali, M., Lopez, A.L., You, Y.A., Kim, Y.E., Sah, B., Maskery, B., et al., 2012. The global burden of cholera. Bull World Health Organ 90, 209-218A.

Arakawa, T., Chong, D.K., Langridge, W.H., 1998. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol 16, 292-297.

Azizi, M., Azizi, F., 2010. History of Cholera Outbreaks in Iran during the 19(th) and 20(th) Centuries. Middle East J Dig Dis 2, 51-55.

Basu, S., Pickett, M.J., 1969. Reaction of Vibrio cholerae and choleragenic toxin in ileal loop of laboratory animals. J Bacteriol 100, 1142-1143.

Bishop, A.L., Schild, S., Patimalla, B., Klein, B., Camilli, A., 2010. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78, 4402-4420.

Borde, A., Larsson, A., Holmgren, J., Nygren, E., 2011. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation. Eur J Pharm Biopharm 79, 508-518.

Boustanshenas, M., Bakhshi, B., Ghorbani, M., 2013. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model. J Appl Microbiol 114, 509-515.

Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the

principle of protein-dye binding. Anal Biochem 72, 248-254.

Chatterjee, D., Chaudhuri, K., 2011. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett 585, 1357-1362.

Chatterjee, D., Chaudhuri, K., 2013. Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses. J Biol Chem 288, 4299-4309.

Claassen, I., Meylis, J., van der Ley, P., Peeters, C., Brons, H., Robert, J., et al., 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14, 1001-1008.

Elson, C.O., Ealding, W., Lefkowitz, J., 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods 67, 101-108.

Harder, T., Koch, J., Wichmann, O., Hellenbrand, W., 2017. Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review. J Infect 75, 81-94.

Holmgren, J., Czerkinsky, C., 2005. Mucosal immunity and vaccines. Nat Med 11, S45-53.

Kim, S.H., Kim, K.S., Lee, S.R., Kim, E., Kim, M.S., Lee, E.Y., et al., 2009. Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta 1788, 2150-2159.

Lebens, M., Karlsson, S.L., Kallgard, S., Blomquist, M., Ekman, A., Nygren, E., et al., 2011. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Vaccine 29, 7505-7513.

Mountford, A.P., Fisher, A., Wilson, R.A., 1994. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol 16, 521-527.

Pourshafie, M.R., Bakhshi, B., Ranjbar, R., Sedaghat, M., Sadeghifard, N., Zaemi Yazdi, J., et al., 2007. Dissemination of a single Vibrio cholerae clone in cholera outbreaks during 2005 in Iran. J Med Microbiol 56, 1615-1619.

Roier, S., Leitner, D.R., Iwashkiw, J., Schild-Prüfert, K., Feldman, M.F., Krohne, G., et al., 2012. Correction:

Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice. PLOS ONE 7, 10.1371/annotation/1370dbc4010-f1114-1342fc-aafa 1373efeef1374d3068.

Schild, S., Nelson, E.J., Bishop, A.L., Camilli, A., 2009. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77, 472-484.

Schild, S., Nelson, E.J., Camilli, A., 2008. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 76, 4554-4563.

Siadat, S.D., Behzadiyannejad, Q., Tabaraie, B., 2007. Evaluation of Serum Bactericidal Activity Specific for Neisseria meningitidis Serogroup A and B: Effect of Immunization with Neisseria meningitidis Serogroup A Polysaccharide and Serogroup B Outer Membrane Vesicle Conjugate as a Bivalent Meningococcus vaccine candidate. Res J Microbial 5, 436- 444.

Sinha, R., Koley, H., Nag, D., Mitra, S., Mukhopadhyay, A.K., Chattopadhyay, B., 2015. Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models. Microbes Infect 17, 215-227.

Vindurampulle, C.J., Attridge, S.R., 2003. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect Immun 71, 287-297.

von Seidlein, L., Jiddawi, M., Grais, R.F., Luquero, F., Lucas, M., Deen, J., 2013. The value of and challenges for cholera vaccines in Africa. J Infect Dis 208 Suppl 1, S8-14.

Wang, Z., Lazinski, D.W., Camilli, A., 2017. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility. Infect Immun 85, 1-9.

WHO, 2005. Oral cholera vaccine use in complex emergencies, what next? Global task force on cholera control, Geneva.